Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1995 Jan 1;181(1):169–179. doi: 10.1084/jem.181.1.169

Autoantibodies to desmoplakin I and II in patients with erythema multiforme

PMCID: PMC2191849  PMID: 7807001

Abstract

Erythema multiforme (EM) represents a syndrome of chronic recurrent inflammatory skin disease. Depending on the severity and extent of skin and mucosal involvement, it is defined either as EM minor or EM major. In this study we demonstrate the presence of autoantibodies (aAbs) against desmoplakin I and II, two major proteins of the desmosomal plaque, in six of six patients with the severe variant of EM, EM major. Light microscopic studies of lesional skin and mucous membranes localized in vivo bound immunoglobulin G (IgG) in a dotted desmosomal pattern along the cytoplasmic membranes of keratinocytes. By immunoelectronmicroscopy, in vivo bound IgG was confined to the desmosomal plaques. These findings were confirmed by indirect immunolocalization studies that demonstrated the presence of IgG aAbs in the serum of patients during active disease. These aAbs did not only bind to desmosomal plaques of epithelial cells where they colocalized with defined murine monoclonal antibodies directed against desmoplakin I and II, but also labeled the intercalated discs of myocardial cells. Biochemical characterization of circulating IgG aAbs revealed desmoplakin I and II as actual target autoantigens. By passive transfer of serum into newborn mice, in vivo binding of serum aAbs to keratinocytes was shown. The findings presented in this study imply a humoral immune response in certain patients with EM major and indicate a potential pathogenetic role of aAbs against desmoplakin I and II in this disease.

Full Text

The Full Text of this article is available as a PDF (3.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amagai M., Klaus-Kovtun V., Stanley J. R. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell. 1991 Nov 29;67(5):869–877. doi: 10.1016/0092-8674(91)90360-b. [DOI] [PubMed] [Google Scholar]
  2. Angst B. D., Nilles L. A., Green K. J. Desmoplakin II expression is not restricted to stratified epithelia. J Cell Sci. 1990 Oct;97(Pt 2):247–257. doi: 10.1242/jcs.97.2.247. [DOI] [PubMed] [Google Scholar]
  3. Anhalt G. J., Kim S. C., Stanley J. R., Korman N. J., Jabs D. A., Kory M., Izumi H., Ratrie H., 3rd, Mutasim D., Ariss-Abdo L. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 1990 Dec 20;323(25):1729–1735. doi: 10.1056/NEJM199012203232503. [DOI] [PubMed] [Google Scholar]
  4. Anhalt G. J., Labib R. S., Voorhees J. J., Beals T. F., Diaz L. A. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med. 1982 May 20;306(20):1189–1196. doi: 10.1056/NEJM198205203062001. [DOI] [PubMed] [Google Scholar]
  5. Bedi T. R., Pinkus H. Histopathological spectrum of erythema multiforme. Br J Dermatol. 1976 Sep;95(3):243–250. doi: 10.1111/j.1365-2133.1976.tb07010.x. [DOI] [PubMed] [Google Scholar]
  6. Beutner E. H., Jordon R. E., Chorzelski T. P. The immunopathology of pemphigus and bullous pemphigoid. J Invest Dermatol. 1968 Aug;51(2):63–80. [PubMed] [Google Scholar]
  7. Blake M. S., Johnston K. H., Russell-Jones G. J., Gotschlich E. C. A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. Anal Biochem. 1984 Jan;136(1):175–179. doi: 10.1016/0003-2697(84)90320-8. [DOI] [PubMed] [Google Scholar]
  8. Bushkell L. L., Mackel S. E., Jordon R. E. Erythema multiforme: direct immunofluorescence studies and detection of circulating immune complexes. J Invest Dermatol. 1980 May;74(5):372–374. doi: 10.1111/1523-1747.ep12543806. [DOI] [PubMed] [Google Scholar]
  9. Duden R., Franke W. W. Organization of desmosomal plaque proteins in cells growing at low calcium concentrations. J Cell Biol. 1988 Sep;107(3):1049–1063. doi: 10.1083/jcb.107.3.1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Green K. J., Parry D. A., Steinert P. M., Virata M. L., Wagner R. M., Angst B. D., Nilles L. A. Structure of the human desmoplakins. Implications for function in the desmosomal plaque. J Biol Chem. 1990 Feb 15;265(5):2603–2612. [PubMed] [Google Scholar]
  11. Green K. J., Virata M. L., Elgart G. W., Stanley J. R., Parry D. A. Comparative structural analysis of desmoplakin, bullous pemphigoid antigen and plectin: members of a new gene family involved in organization of intermediate filaments. Int J Biol Macromol. 1992 Jun;14(3):145–153. doi: 10.1016/s0141-8130(05)80004-2. [DOI] [PubMed] [Google Scholar]
  12. Hashimoto T., Ogawa M. M., Konohana A., Nishikawa T. Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources. J Invest Dermatol. 1990 Mar;94(3):327–331. doi: 10.1111/1523-1747.ep12874456. [DOI] [PubMed] [Google Scholar]
  13. Howland W. W., Golitz L. E., Weston W. L., Huff J. C. Erythema multiforme: clinical, histopathologic, and immunologic study. J Am Acad Dermatol. 1984 Mar;10(3):438–446. doi: 10.1016/s0190-9622(84)80090-0. [DOI] [PubMed] [Google Scholar]
  14. Huff J. C., Weston W. L., Tonnesen M. G. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol. 1983 Jun;8(6):763–775. doi: 10.1016/s0190-9622(83)80003-6. [DOI] [PubMed] [Google Scholar]
  15. Klymkowsky M. W. Intermediate filaments in 3T3 cells collapse after intracellular injection of a monoclonal anti-intermediate filament antibody. Nature. 1981 May 21;291(5812):249–251. doi: 10.1038/291249a0. [DOI] [PubMed] [Google Scholar]
  16. Klymkowsky M. W., Miller R. H., Lane E. B. Morphology, behavior, and interaction of cultured epithelial cells after the antibody-induced disruption of keratin filament organization. J Cell Biol. 1983 Feb;96(2):494–509. doi: 10.1083/jcb.96.2.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Labib R. S., Anhalt G. J., Patel H. P., Mutasim D. F., Diaz L. A. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol. 1986 Feb 15;136(4):1231–1235. [PubMed] [Google Scholar]
  18. Ma A. S., Lorincz A. L. Immunofluorescence localization of peripheral proteins in cultured human keratinocytes. J Invest Dermatol. 1988 Mar;90(3):331–335. doi: 10.1111/1523-1747.ep12456204. [DOI] [PubMed] [Google Scholar]
  19. Margolis R. J., Tonnesen M. G., Harrist T. J., Bhan A. K., Wintroub B. U., Mihm M. C., Jr, Soter N. A. Lymphocyte subsets and Langerhans cells/indeterminate cells in erythema multiforme. J Invest Dermatol. 1983 Nov;81(5):403–406. doi: 10.1111/1523-1747.ep12522001. [DOI] [PubMed] [Google Scholar]
  20. Mutasim D. F., Morrison L. H., Takahashi Y., Labib R. S., Skouge J., Diaz L. A., Anhalt G. J. Definition of bullous pemphigoid antibody binding to intracellular and extracellular antigen associated with hemidesmosomes. J Invest Dermatol. 1989 Feb;92(2):225–230. doi: 10.1111/1523-1747.ep12276753. [DOI] [PubMed] [Google Scholar]
  21. O'Keefe E. J., Erickson H. P., Bennett V. Desmoplakin I and desmoplakin II. Purification and characterization. J Biol Chem. 1989 May 15;264(14):8310–8318. [PubMed] [Google Scholar]
  22. Orfanos C. E., Schaumburg-Lever G., Lever W. F. Dermal and epidermal types of erythema multiforme. A histopathologic study of 24 cases. Arch Dermatol. 1974 May;109(5):682–688. [PubMed] [Google Scholar]
  23. Oursler J. R., Labib R. S., Ariss-Abdo L., Burke T., O'Keefe E. J., Anhalt G. J. Human autoantibodies against desmoplakins in paraneoplastic pemphigus. J Clin Invest. 1992 Jun;89(6):1775–1782. doi: 10.1172/JCI115781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rappersberger K., Roos N., Stanley J. R. Immunomorphologic and biochemical identification of the pemphigus foliaceous autoantigen within desmosomes. J Invest Dermatol. 1992 Sep;99(3):323–330. doi: 10.1111/1523-1747.ep12616659. [DOI] [PubMed] [Google Scholar]
  25. Stanley J. R. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv Immunol. 1993;53:291–325. doi: 10.1016/s0065-2776(08)60503-9. [DOI] [PubMed] [Google Scholar]
  26. Stanley J. R., Koulu L., Klaus-Kovtun V., Steinberg M. S. A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus. J Immunol. 1986 Feb 15;136(4):1227–1230. [PubMed] [Google Scholar]
  27. Stanley J. R., Koulu L., Thivolet C. Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J Clin Invest. 1984 Aug;74(2):313–320. doi: 10.1172/JCI111426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stanley J. R. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. J Clin Invest. 1989 May;83(5):1443–1448. doi: 10.1172/JCI114036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Stanley J. R., Yaar M., Hawley-Nelson P., Katz S. I. Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. J Clin Invest. 1982 Aug;70(2):281–288. doi: 10.1172/JCI110615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Stanley J. R., Yuspa S. H. Specific epidermal protein markers are modulated during calcium-induced terminal differentiation. J Cell Biol. 1983 Jun;96(6):1809–1814. doi: 10.1083/jcb.96.6.1809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Stappenbeck T. S., Bornslaeger E. A., Corcoran C. M., Luu H. H., Virata M. L., Green K. J. Functional analysis of desmoplakin domains: specification of the interaction with keratin versus vimentin intermediate filament networks. J Cell Biol. 1993 Nov;123(3):691–705. doi: 10.1083/jcb.123.3.691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Stappenbeck T. S., Green K. J. The desmoplakin carboxyl terminus coaligns with and specifically disrupts intermediate filament networks when expressed in cultured cells. J Cell Biol. 1992 Mar;116(5):1197–1209. doi: 10.1083/jcb.116.5.1197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tanaka T., Parry D. A., Klaus-Kovtun V., Steinert P. M., Stanley J. R. Comparison of molecularly cloned bullous pemphigoid antigen to desmoplakin I confirms that they define a new family of cell adhesion junction plaque proteins. J Biol Chem. 1991 Jul 5;266(19):12555–12559. [PubMed] [Google Scholar]
  34. Thacher S. M., Hefti P. L. Characterization of 230-kD bullous pemphigoid antigen associated with the detergent-insoluble fraction of cultured keratinocytes. J Invest Dermatol. 1991 Jan;96(1):139–143. doi: 10.1111/1523-1747.ep12515936. [DOI] [PubMed] [Google Scholar]
  35. Tokuyasu K. T. Application of cryoultramicrotomy to immunocytochemistry. J Microsc. 1986 Aug;143(Pt 2):139–149. doi: 10.1111/j.1365-2818.1986.tb02772.x. [DOI] [PubMed] [Google Scholar]
  36. Tonnesen M. G., Harrist T. J., Wintroub B. U., Mihm M. C., Jr, Soter N. A. Erythema multiforme: microvascular damage and infiltration of lymphocytes and basophils. J Invest Dermatol. 1983 Apr;80(4):282–286. doi: 10.1111/1523-1747.ep12534652. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES